OncoCyte Corp (NASDAQ:OCX)
| 3.60 BATS BZX Real-Time Price As of 11:34am ET |  -0.38 / -9.55%Today’s Change | 2.08 Today|||52-Week Range 10.00 | -43.91% Year-to-Date |
Latest OCX News | Press Releases
No recent news for OncoCyte Corp.
Today’s Trading
| Previous close | 3.98 |
| Today’s open | 3.65 |
| Day’s range | 3.60 - 3.65 |
| Volume | 138 |
| Average volume (3 months) | 16,754 |
| Market cap | $32.1M |
Data as of 11:34am ET, 12/05/2023
Growth & Valuation
| Earnings growth (last year) | +8.07% |
| Earnings growth (this year) | +98.83% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -87.60% |
| P/E ratio | NM |
| Price/Sales | 37.11 |
| Price/Book | 0.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLGLSol Gel Technologies... | +0.07 | +5.74% |
| NLTXNeoleukin Therapeuti... | 0.00 | 0.00% |
| PTNPalatin Technologies... | -0.07 | -2.97% |
| ELDNEledon Pharmaceutica... | -0.02 | -1.50% |
Data as of 11:24am ET, 12/05/2023
Financials
| Next reporting date | April 1, 2024 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $958.0K |
| Annual profit (last year) | -$72.9M |
| Net profit margin | -1,942.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
